We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Moleculin

News List

Moleculin Announces Significant Discovery in Lung Cancer Models americanpharmaceuticalreview
April 22, 2019
Moleculin Announces Significant Discovery in Lung Cancer Models...
Moleculin Announces FDA Filing for Orphan Drug Designation for Glioblastoma Drug americanpharmaceuticalreview
December 10, 2018
Moleculin Biotech, Inc., a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license ....
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia firstwordpharma
March 23, 2017
Moleculin Biotech, Inc. announced its lead candidate, Annamycin (also known as "Liposomal Annamycin"), an anthracycline, has received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML).

Previous page 1 2 Next page